AstraZeneca PLC is 152.3x more valuable than Sarepta Therapeutics, Inc. by market capitalization ($286.27 B vs $1.88 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SRPT | AZN |
|---|---|---|
| Market cap | $1.88 B | $286.27 B |
| US-listed rank | #2138 | #45 |
| Revenue (latest FY) | $1.86B | - |
| Net income (latest FY) | -$713.41M | - |
| Net margin | -38.3% | - |
| SEC filings | 1,504 | 1,004 |
AstraZeneca PLC is 152.3x more valuable than Sarepta Therapeutics, Inc. by market capitalization ($286.27 B vs $1.88 B).
Full pages: Sarepta Therapeutics, Inc. and AstraZeneca PLC, or browse the full rankings.